Experimental phage therapy against Staphylococcus aureus in mice

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 8, 2007, Pages 2765-2773

  Capparelli, Rosanna ^a   Parlato, Marianna ^a   Borriello, Giorgia ^a   Salvatore, Paola ^a   Iannelli, Domenico ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABSCESS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIOPHAGE; BACTERIOPHAGE M SA; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANIMALS; COLONY COUNT, MICROBIAL; FEMALE; HUMANS; MACROPHAGES, PERITONEAL; METHICILLIN RESISTANCE; MICE; MICE, INBRED BALB C; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PHAGES;

EID: 34547623422     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01513-06     Document Type: Article

References (37)

1. Adams, M. H. 1959. Methods of study of bacterial viruses, p. 447-448. In Bacteriophages. Interscience Publishers, London, United Kingdom.
2. Becker, K., R. Roth, and G. Peters. 1998. Rapid and specific detection of toxigenic Staphylococcus aureus: use of two multiplex PCR enzyme immunoassays for amplification and hybridization of staphylococcal enterotoxin genes, exfoliative toxin genes, and toxic shock syndrome toxin 1 gene. J. Clin. Microbiol. 36:2548-2553.
3. Binetti, A. G., B. Del Río, M. Cruz Martìn, and M. A. Álvarez. 2005. Detection and characterization of Streptococcus thermophilus bacteriophages by use of the antireceptor gene sequence. Appl. Environ. Microbiol. 71:6069-6103.
4. Biswas, B., S. Adhya, P. Washart, B. Paul, A. N. Trostel, B. Powell, R. Carlton, and C. R. Merril. 2002. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect. Immun. 70:204-210.
5. Broxmeyer, L., D. Sosnowska, E. Miltner, O. Chacon, D. Wagner, J. McGarvey, R. G. Barletta, and L. E. Bermudez. 2002. Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens. J. Infect. Dis. 186:1155-1160.
6. Bull, J. J., B. R. Levin, T. DeRouin, N. Walker, and C. A. Bloch. 2002. Dynamics of success and failure in phage and antibiotic therapy in experimental infections. BMC Microbiol. 2:35.
7. Bull, J. J., and R. R. Regoes. 2006. Pharmacodynamics of non-replicating viruses, bacteriocins and lysins. Proc. Biol. Sci. 273:2703-2712.
8. Capparelli, R., I. Ventimiglia, S. Roperto, D. Fenizia, and D. Iannelli. 2006. Selection of an Escherichia coli O157:H7 bacteriophage for persistence in the circulatory system of mice infected experimentally. Clin. Microbiol. Infect. 12:248-253.
9. Clement, S., P. Vaudaux, P. Francois, J. Schrenzel, E. Huggler, S. Kampf, C. Chaponnier, D. Lew, and J. S. Lacroix. 2005. Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis. J. Infect. Dis. 192:1023-1028.
10. Dixon, B. 2004. New dawn for phage therapy. Lancet Infect. Dis. 4:186.
11. Fischetti, V. 2004. Vincent Fischetti - following phages for life. Lancet Infect. Dis. 4:246-249.
12. Foster, J. F. 2005. Immune evasion by staphylococci. Nat. Rev. Microbiol. 3:948-958.
13. Jarraud, S., C. Mougel, J. Thioulouse, G. Lina, H. Meugnier, F. Forey, X. Nesme, J. Etienne, and F. Vandenesch. 2002. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect. Immun. 70:631-641.
14. Lederberg, J. 1996. Smaller fleas ... ad infinitum: therapeutic bacteriophage redux. Proc. Natl. Acad. Sci. USA 93:3167-3168.
15. Leeb, M. 2004. Antibiotics: a shot in the arm. Nature 431:892-893.
16. Leid, J. G., M. E. Shirtliff, J. W. Costerton, and P. Stoodley. 2002. Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect. Immun. 70:6339-6345.
17. Levin, B. R., and D. E. Rozen. 2006. Non-inherited antibiotic resistance. Nat. Rev. Microbiol. 4:556-561.
18. Levin, B. R., and R. Antia. 2001. Why we do not get sick: the within host dynamics of bacterial infections. Science 292:1112-1115.
19. Levy, S. B., and B. Marshall. 2004. Antibacterial resistance worldwide: causes, challenges and responses. Nat. Med. 10:122-129.
20. Lowy, F. D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339: 520-532.
21. Mason, W. J., J. S. Blevins, K. Beenken, N. Wibowo, N. Ojma, and M. S. Smeltzer. 2001. Multiplex PCR protocol for the diagnosis of staphylococcal infections. J. Clin. Microbiol. 39:3332-3338.
22. Matsuzaki, S., M. Yasuda, H. Nishikawa, M. Kuroda, T. Ujihara, T. Shuin, Y. Shen, Z. Jin, S. Fujmoto, M. D. Nasimuzzan, H. Wakiguchi, S. Suguhara, T. Sugiura, S. Koda, A. Muraoka, and S. Imai. 2003. Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage φMR11. J. Infect. Dis. 187:613-624.
23. McClean, K. L., G. J. Sheehan, and K. M. Harding. 1994. Intraabdominal infection: a review. Clin. Infect. Dis. 19:100-116.
24. Mehrotra, M., G. Wang, and W. M. Johnson. 2000. Multiplex PCR for detection of genes for Staphylococcus aureus enterotoxins, exfoliative toxins, toxic shock syndrome toxin 1, and methicillin resistance. J. Clin. Microbiol. 38:1032-1035.
25. Merril, C. R., B. Biswas, R. Carlton, N. C. Jensen, G. J. Creed, S. Zullo, and S. Adhya. 1996. Long circulating bacteriophage as antibacterial agents. Proc. Natl. Acad. Sci. USA 93:3188-3192.
26. Palliser, D., D. Chowdhury, Q. Y. Wang, S. J. Lee, R. T. Bronson, D. M. Knipe, and J. Lieberman. 2006. An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature 439:89-94.
27. Payne, J. H., and V. A. Jansen. 2000. Phage therapy: the peculiar kinetics of self-replicating pharmaceutical. Clin. Pharmacol. Ther. 68:225-229.
28. Qazi, S. N., S. E. Harrison, T. Self, P. Williams, and J. Hill. 2004. Real-time monitoring of intracellular Staphylococcus aureus replication. J. Bacteriol. 186:1065-1077.
29. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
30. Smith, H. W., M. B. Huggins, and K. M. Shaw. 1987. The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages. J. Gen. Microbiol. 133:1111-1126.
31. Stearne, L. E., I. C. Gyssens, W. H. Goessens, J. W. Mouton, W. J. Oyen, J. W. Van der Meer, and H. A. Verbrugh. 2001. In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model. Antimicrob. Agents Chemother. 45:1394-1401.
32. Sulakvelidze, A., Z. Alavidze, and J. G. Morris, Jr. 2001. Bacteriophage therapy. Antimicrob. Agents Chemother. 45:649-659.
33. Tenover, F. C., L. M. Weigel, P. C. Appelbaum, L. K. McDougal, J. Chaitram, S. McAllistar, N. Clark, G. Killgore, C. M. O'Hara, L. Jevitt, J. B. Patel, and B. Bozdogan. 2004. Vancomycin-resistant isolate from a patient in Pennsylvania. Antimicrob. Agents Chemother. 48:275-280.
34. Weigel, L. M., D. B. Clewell, S. R. Gill, N. C. Clark, L. K. McDougal, S. E. Flannagan, J. F. Kolonay, J. Shetty, G. E. Killgore, and F. C. Tenover. 2003. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 302:1569-1571.
35. Westwater, C., L. M. Kasman, A. Schofield, P. A. Werner, J. W. Dolan, M. G. Schmidt, and J. S. Norris. 2003. Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections. Antimicrob. Agents Chemother. 47:1301-1307.
36. Wiggins, B. A., and M. Alexander. 1985. Minimum bacterial density for bacteriophage replication: implications for significance of bacteriophages in natural ecosystems. Appl. Environ. Microbiol. 49:19-23.
37. Wills, Q. F., C. Kerrigan, and J. S. Soothill. 2005. Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model. Antimicrob. Agents Chemother. 49:1220-1221.